Image-guided stereotactic management of non-AIDS-related cerebral infection
- PMID: 1633461
Image-guided stereotactic management of non-AIDS-related cerebral infection
Abstract
Every neurosurgeon can appreciate Dandy's recognition that the drainage of brain abscesses causes trauma to the delicate parenchyma. Over the years, brain surgery has evolved toward management of problems by using less and less invasive techniques and thus gaining ever lower morbidity. Clearly, the advent of better imaging techniques has improved the outcome in patients afflicted with intracerebral infections. The combination of stereotaxy with these imaging techniques is contributing a "zero mortality" in the treatment of these infections. In our series of 29 consecutive patients with non-AIDS-related infections, no patient died as a direct result of a stereotactic surgical procedure. Two patients (7%) had new neurologic deficits after surgery. The only patient left with a permanent disability had a kidney allograft and subacute bacterial endocarditis. His condition deteriorated 6 hours after aspiration of a sterile abscess, when an intra-abscess hematoma was diagnosed and evacuated. In retrospect, this complication may have been avoided by less vigorous aspiration. Three of the four patients with nonviral infections who died were iatrogenically immunosuppressed for their organ transplants. These patients are difficult to treat, and given the current popularity of transplantation procedures, neurosurgeons will face more and more opportunistic infections. In general, the patients with abscesses did well. On the other hand, nonoperative mortality was extremely high for patients with viral encephalitides. This high mortality may have resulted from a delay in diagnosis and treatment or from the unavailability of highly effective antiviral agents at the time the biopsies were performed. The importance of early diagnosis and treatment of infection cannot be overemphasized. T.H. Flewett's warning about the management of HSE applies to the management of all cerebral infections: "It seems clear from everybody's published results [in the papers already given] if we wait to do biopsy until the clinical indications are unmistakable, we have waited so long that the patient, if he survives, will be left a severe neurological cripple." Because it is relatively noninvasive, stereotactic neurosurgery has been used increasingly to diagnose brain masses in patients with AIDS. We recommend its use for establishing diagnoses in all suspected cases of cerebral infection. We agree with Rosenblum et al: Empiric treatment of brain infections should be regarded as "radical." Such treatment should be reserved for patients who have an identifiable source of infection and causative organism or for patients who are clinically too unstable to undergo surgery.(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
Factors that enhance the likelihood of successful stereotactic treatment of brain abscesses.Acta Neurochir (Wien). 1994;127(1-2):85-90. doi: 10.1007/BF01808553. Acta Neurochir (Wien). 1994. PMID: 7942189
-
Computerized tomography-guided stereotactic aspiration of brain abscesses: experience with 28 cases.Zhonghua Yi Xue Za Zhi (Taipei). 1999 Jun;62(6):341-9. Zhonghua Yi Xue Za Zhi (Taipei). 1999. PMID: 10389291
-
Stereotactic drainage of brain abscesses.Neurol Res. 1987 Dec;9(4):270-4. doi: 10.1080/01616412.1987.11739807. Neurol Res. 1987. PMID: 2895905
-
[Brain abscess--modern diagnostics and therapeutic treatment].Przegl Epidemiol. 2009;63(1):89-95. Przegl Epidemiol. 2009. PMID: 19522234 Review. Polish.
-
Management of brain abscess: an overview.Neurosurg Focus. 2008;24(6):E3. doi: 10.3171/FOC/2008/24/6/E3. Neurosurg Focus. 2008. PMID: 18518748 Review.
Cited by
-
Bedside twist drill aspiration of cerebral abscess less than 2.5 cm in size: A case series and discussion.Surg Neurol Int. 2017 Sep 26;8:230. doi: 10.4103/sni.sni_291_16. eCollection 2017. Surg Neurol Int. 2017. PMID: 29026666 Free PMC article.
-
Biodegradable drug-eluting poly[lactic-co-glycol acid] nanofibers for the sustainable delivery of vancomycin to brain tissue: in vitro and in vivo studies.ACS Chem Neurosci. 2013 Sep 18;4(9):1314-21. doi: 10.1021/cn400108q. Epub 2013 Jul 12. ACS Chem Neurosci. 2013. PMID: 23815098 Free PMC article.